Tools
Tools
Liew, David F. L., Mackie, Sarah L., Tison, Alice, Sattui, Sebastian E., Yates, Max 
ORCID: https://orcid.org/0000-0003-3977-8920, Buchanan, Russell R. C. and Owen, Claire E.
(2024)
Immune checkpoint inhibitor-induced polymyalgia rheumatica.
Rheumatic Disease Clinics of North America, 50 (2).
pp. 255-267.
ISSN 0889-857X
| Item Type: | Article |
|---|---|
| Additional Information: | Funding Information: MY reports advisory board fees for BioGen.SES is by the Bristol Myers Squibb Foundation Robert A. Winn Diversity in Clinical Trials Career Development Award. SES has received research funding from AstraZeneca and GlaxoSmithKline (clinical trials) and participated in consulting and advisory boards for Sanofi and Amgen (funds toward research support). SES has received speaker fees from Fresenius Kabi (funds toward research support). |
| Uncontrolled Keywords: | disease model,immune-related adverse event,mimics,paraneoplastic,pd-1 agonist,pd-1 inhibitor,peresolimab,polymyalgia rheumatica,rheumatology ,/dk/atira/pure/subjectarea/asjc/2700/2745 |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Science > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 12 Sep 2024 13:30 |
| Last Modified: | 25 Sep 2024 17:56 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/96742 |
| DOI: | 10.1016/j.rdc.2024.02.001 |
Actions (login required)
 |
View Item |